Radiopharm Theranostics Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Radiopharm Theranostics Limited (ASX: RPH) covers the month of August 2026, with a report date of August 27, 2026. The filing serves to disclose a specific corporate governance event rather than financial performance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of director interest changes and contains no financial statements or operational metrics.
Material Changes
The material change disclosed is the publication of four "Change of Director's Interest Notices" on the Australian Securities Exchange. No financial or operational changes versus prior periods are reported in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, risk factors, or discussion of unusual items. It strictly references the attached exhibit regarding director shareholding changes.
Key Facts for Investor Verification
- Verify the specific nature of the four director interest changes in the attached Exhibit 99.1.
- Confirm the identity of the directors involved in the interest changes.
- Note that this filing does not impact the company's financial position or operational outlook.